A Single Case Experiment Design Investigating Wisdom Enhancement to Augment CBT Outcomes for Depression in Post-Stroke Populations
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 3
- 试验地点
- 2
- 主要终点
- Visual Analogue Scale (VAS) - Identity
研究概览
简要总结
One-third of stroke survivors experience post-stroke depression, but there are currently no official guidelines for supporting them. Researchers aim to investigate whether the wisdom enhancement timeline technique can reduce depression in stroke survivors. The investigators also want to understand how this technique positively impacts mood, identity, self-esteem, and wisdom. The study will involve nine stroke survivors from the National Health Service (NHS) to gain insights into effective ways to support those with post-stroke depression.
详细描述
One-third of stroke survivors have post-stroke depression. Finding ways to help them feel more positive after such a challenging event can be tricky. Right now, there are no official guidelines on the best way to support post-stroke depression, and research into this is still growing. That is why the investigators want to see if the wisdom enhancement timeline can improve the mood and overall well-being of people who have had a stroke.
In this study, the investigators have two goals. First, the investigators want to see if the wisdom enhancement timeline technique can reduce depression in stroke survivors. Second, the investigators aim to discover how this technique brings positive mood changes.
The main question the investigators want to answer
- Does enhancing wisdom through the timeline technique improve psychological outcomes (mood, identity, self-esteem) in post-stroke depressed individuals?
- In post-stroke depressed individuals, is the improvement in wisdom the first indicator of subsequent improvements in identity, self-esteem, and mood?
It is hypothesised that wisdom will improve first following the session where wisdom is applied. This will then be followed by either identity or self-esteem, with mood improving last.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Had a stroke.
- •Those who self-report as having difficulties with depression to a clinician.
- •Have sufficient cognitive and communication abilities for informed consent and active engagement
排除标准
- •Under the age of
- •Because this is the age when they are treated as an adult by UK law.
- •Severe cognitive impairments or mental health difficulties that would hinder task engagement or provide informed consent.
- •Medical instability jeopardising consistent participation or well-being.
- •Significant risk concerns regarding safety to themselves or others.
- •Substance use/dependency impacting adherence.
- •Prescribed psychotropic medication less than 3 months ago.
- •Currently involved in research.
结局指标
主要结局
Visual Analogue Scale (VAS) - Identity
时间窗: Daily during baseline phase and intervention phase (total of 8-10 weeks depending on baseline length)
A single-item Visual Analogue Scale was used to assess identity, rated daily on a 0-10 scale, where 0 indicates "a disconnect from who they are" and 10 indicates "complete connection." Three participants recorded their rating once each day throughout the baseline and intervention phases.
Visual Analogue Scale (VAS) - Wisdom
时间窗: Daily during baseline phase and intervention phase (total of 8-10 weeks depending on baseline length)
A single-item Visual Analogue Scale was used to assess Wisdom, rated daily on a 0-10 scale, where 0 indicates "low wisdom" and 10 indicates "high wisdom." Participants recorded their rating once each day throughout the baseline and intervention phases.
Visual Analogue Scale (VAS) - Self-esteem
时间窗: Daily during baseline phase and intervention phase (total of 8-10 weeks depending on baseline length)
A single-item Visual Analogue Scale was used to assess self-esteem, rated daily on a 0-10 scale, where 0 indicates "low self-esteem" and 10 indicates "high self-esteem." Participants recorded their rating once each day throughout the baseline and intervention phases.
Visual Analogue Scale (VAS) - Mood
时间窗: Daily during baseline phase and intervention phase (total of 8-10 weeks depending on baseline length)
A single-item Visual Analogue Scale was used to assess mood, rated daily on a 0-10 scale, where 0 indicates "worst possible mood" and 10 indicates "best possible mood." Three participants recorded their rating once each day throughout the trial.
次要结局
- Patient Health Questionnaire (PHQ-9)(Baseline to end of 6-week intervention phase)